Tag: Production

Domestic Coal Production Goes up by 28% as of 16 June, 2022

June 19, 2022.Reading time less than 1 minute.

Ministry of Coal:

  • Domestic Coal Production Goes up by 28% as of 16 June, 2022

  • Total Production Touches Nearly 138 Million Ton  as on  31st May, 2022-23

  • Adequate Coal Supply to Power Sector Ensured on Sustained Basis

  • Coal Stock At Different Mines Touches 52 Million Ton, Sufficient For 24 Days’  Power Sector Requirement

  • Short & Long Term Tenders Floated by Coal India Ltd for Coal Import

    Please click here to read more:
    https://pib.gov.in/PressReleasePage.aspx?PRID=1835211

Coal Production increases by 29% to 66.58 Million Ton During April, 2022

May 10, 2022.Reading time 1 minute.

Ministry of Coal:

As per the provisional statistics of Ministry of Coal, the total coal production increased by 29% to 66.58 Million Ton (MT) from 51.62 MT in April, 2022 as compared to April, 2021.

During April, 2022, Coal India Ltd. (CIL), Singareni Collieries Company Ltd. (SCCL) and Captive mines/Others registered a growth of 27.64%, 9.59% and 59.98% by producing 53.47 MT, 5.32 MT and 7.79 MT of coal respectively.

At the same time, coal despatch increased by 8.66% to 71.30 MT from 65.62 MT during April, 2022 as compared to April, 2020.

During April 2022, CIL, SCCL and Captive/Others registered a growth of 6.01%, 5.53% and 35.69% by despatching 57.50 MT, 5.74 MT and 8.06 MT respectively.

Of the top 37 coal producing mines, 22 have performed more than 100 % and another 10 mines’ production stood between 80 and 100 per cent.

The Power utilities coal despatch has gone up by 18.15 % to 61.81 MT during April, 2022 as compared to 52.32 MT in April, 2020.

Fall in import prices of coal have been observed since the end of October last year. However, international prices are still at high level.

Coal based power generation has registered a growth of 9.26% last month as compared to April 2021 and growth of 2.25% as compared to Mar 2022.

The overall power generation in April, 2022 has been 11.75% higher than the power generated in April, 2021 and 2.23% higher than power generated in Mar 2022.

Coal based power generation in the month of April, 2022 has been 102529 MU in comparison to 100276 MU in March, 2022 and registered a growth of 2.25 %.

Total power generation has also increased in April, 2022 to 136565 MU from 133584 MU in March, 2022.

Click here for More news
Follow us on twitter
follow us on facebook

Remdesivir production to be doubled in coming weeks: Sadananda Gowda

April 19, 2021.Reading time less than 1 minute.

DV Sadananda Gowda – Union Minister:

Took a meeting with Secretary (Pharma) to review availability of Remdesivir.

Government is in regular touch with manufacturers regarding this. Weekly production plans have been prepared in consultation with the manufacturers.

Manufacturers have agreed to ramp up production of Remdesivir. Additional sites for production have been approved. Production to be doubled in coming weeks.

Black marketing/hoarding is being strictly monitored and State Governments have been advised to take strict action against those indulging in such malpractices.

The current production capacity of Covaxin vaccine will be increased from 1 crore vaccine doses in April, 2021 to 6-7 crore vaccine dose/month in July – August

April 16, 2021.Reading time 3 minutes.

Ministry of Science & Technology via PIB India:

Under Atmanirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production of Indigenous COVID Vaccines. This is being implemented by Department of Biotechnology Govt. of India.

Under the Mission the Department of Biotechnology Govt of India is providing financial support as Grant to vaccine manufacturing facilities for enhanced production capacities. The current production capacity of indigenously developed Covaxin vaccine will be
doubled by May-June 2021 and then
increased nearly 6-7 fold by July – August 2021 
i.e increasing the production from 1 crore vaccine doses in April, 2021 to 6-7 crore vaccine dose/month in July – August.

It is expected to reach nearly 10 crore doses per month by Sep 2021.

Few weeks back, Inter-ministerial teams had visited the sites of 2 main vaccine manufacturers in India to get their inputs on how production can be ramped up.

In this period, there have been extensive reviews and feasibility studies on the plans being discussed with vaccine manufacturers.

As a part this augmentation plan, capacities of Bharat Biotech Limited, Hyderabad as well as other public sector manufactures are being upgraded with required infrastructure and technology.

Financial support is being provided as grant from GoI to the tune of appx Rs 65 Cr to Bharat Biotech’s new Bangalore facility which is being repurposed to increase the capacity of vaccine production.

3 public sectors companies are also being supported to increase the capacity of vaccine production.

· Haffkine Biopharmaceutical Corporation Ltd, Mumbai –a State PSE under State Govt of Maharashtra.

Financial support as grant from GoI to the tune of appx Rs 65 Cr will be provided for this facility to be made ready for manufacturing.

The Haffkine Biopharmaceuticals Ltd had asked for around 12 months to complete this task. However, the Central government has asked them to expedite and complete the task urgently within 6 months.

The facility will have a capacity of 20 million dozes per month, once functional.

· Indian Immunologicals Limited (IIL), Hyderabad –A facility under National Dairy Development Board and Bharat Immunologicals and Biologicals Limited (BIBCOL) , Bulandshahr  a CPSE under Department of Biotechnology ,Govt of India will also be supported to prepare their facility to provide 10-15 million dozes per month by Aug – Sep 2021.

Government approves stepping up of production of Remdesivir

April 14, 2021.Reading time 2 minutes.

Ministry of Chemicals and Fertilizers:

The issue of availability of Remdesivir was reviewed by Shri Mansukh Mandaviya, Minister of State for Chemicals& Fertilizers, Government of India in meetings with the all-existing manufacturers of the Remdesivir drug and other stakeholders on 12th and 13th April 2021, where decisions have been taken to increase production/supply and reduce prices of Remdesivir.

The current total installed capacity of the seven manufacturers of Remdesivir is 38.80 lakh vials per month.

Fast-track approval has been given for seven additional sites having the production capacity of 10 Lakh vials /month to six manufacturers.

Another 30 lakh vials/month production is lined up. This would ramp up the production capacity for manufacturing to around 78 lakh vials/month.

As an additional measure, Remdesivir, API and formulation were placed under Export ban on 11.04.2021 by DGFT to increase the supply of Remdesivir in the Domestic Market.

On Government intervention, Remdesivir supplies of approximately 4 lakh vials meant for Export is being diverted by manufacturers to fulfil domestic requirement. EOU/SEZ units are also being enabled to supply to the domestic market.

Manufacturers of Remdesivir have volunteered to reduce the price to less than Rs 3500 by the end of this week, to support the efforts of  Prime Minister Shri Narendra Modi, to Fight against COVID,

Manufactures of Remdesivir have been directed to give priority to fulfil hospital/institutional level supplies.

Enforcement Authorities of States and Central Govt. have been directed by DCGI to take immediate action on incidence of black-marketing, hoarding and overcharging of Remdesivir.

National Pharmaceutical Pricing Authority (NPPA) is continuously monitoring the availability of  Remdesivir.